Lexington, MA, United States of America

Hong-Ren Wang

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dare Mb Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong-Ren Wang. Retrieved from https://idiyas.com/inventor/hong-ren-wang-3ddbvmbr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hong-Ren Wang

Introduction

Hong-Ren Wang is an accomplished inventor based in Lexington, MA (US). He is currently associated with Dare Mb Inc., where he focuses on developing advanced drug delivery systems. Despite having no granted patents to his name, Wang's innovative ideas are reflected in his patent applications.

Latest Patent Applications

One of Wang's notable patent applications is for a Two Stage Microchip Drug Delivery Device and Methods. This invention provides a sophisticated approach to controlled drug delivery to patients. The device may include one or two microchip elements, each featuring a body portion with drug release apertures in fluid communication with containment reservoirs. These apertures are sealed by reservoir caps that can be electrically activated to release the drug. The device also incorporates a drug formulation within the containment reservoir and at least one drug-permeable membrane. In some designs, an outer housing is positioned away from the microchip's exterior wall, which includes the drug-permeable membrane, creating a depot space for enhanced drug delivery.

Conclusion

Hong-Ren Wang's work at Dare Mb Inc. showcases his commitment to advancing medical technology through innovative drug delivery solutions. His contributions, although not yet reflected in granted patents, hold significant potential for the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…